Clinical Trial Update: A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1, single-centre randomized study evaluated the safety and tolerability of GSK573719 in healthy volunteers. The trial is sponsored by GlaxoSmithKline an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED